2，Tavares IA,Bishai PM,Bennett A.Activity of nimesulide on constitutive and inducible cyclooxygenases.Arzneimittelforschung,1995,45:1093-1095.
3，Famaey JP.In vitro and in vivo pharmacological evidence of sel ective cyclooxygenase-2 inhibition by nimesulide:an overview.Inflamm Res,1997,46:437-446.
4，Churchill L,Graham AG,Shih CK,et al.Selective inhibition of human cycl o-oxygenase-2 by meloxicam. Inflammopharmacol,1996,4:125-135.
5，Noble S,Balfour JA.Meloxicam.Drugs,1996,51:424-430.
6，Patrignani P,Panara MR,Sciulli MG,et al.Differential inhibition of hum an prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal antiinflammato ry drugs.J Physiol Pharmacol,1997,48:623-631.
7，Davis R,Brogden RN.Nimesulide: an update of its pharmacodynamic and ph armacokinetic properties,and therapeutic efficacy.Drugs,1994,48:431-454.
8，Huskisson EC,Ghozlan R,Kurthen R,et al.A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthrit is.Br J Rheumatol,1996,35(Suppl 1):29-34.
9，Hawkey C,Kahan A,Steinbruck K,et al.Gastrointestinal tolerability of m eloxicam compared to diclofenac in osteoarthritis patients.Br J Rheumatol,1998,37:937-945.
上一页 1 2 3 [4]
